CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

Oct 13, 2020 · 38 min · 27.8 MB

0:00-38:29

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

We love to hear from our listeners. Send us a message.

Controlling the cost of personalized medicine: We go behind the scenes of the effort to build a system that simplifies production and reduces the cost of non-viral T cell therapies with Ziopharm Oncology CEO Laurence Cooper, M.D., Ph.D.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/